Description

Vital Chemtech Limited's equity shares will migrate from NSE SME Emerge platform to the Capital Market Segment (Main Board) effective March 11, 2026. The stock will trade under symbol VITAL with ISIN INE0L4K01016.

Summary

Vital Chemtech Limited will migrate its equity shares from the NSE SME Emerge platform to the Capital Market Segment (Main Board) effective March 11, 2026. The migration follows the original listing on SME Emerge on November 11, 2022 (circular NSE/CML/54385). The stock will continue to trade under the symbol VITAL with the same ISIN.

Key Points

  • Effective date of migration to Main Board: March 11, 2026
  • NSE Symbol: VITAL
  • ISIN: INE0L4K01016
  • Series: EQ
  • Face Value: Rs. 10/- per share
  • Total number of securities: 23,951,100 equity shares
  • Distinctive number range: 1 to 23,951,100
  • Market lot size: 1
  • Shares are pari passu; no lock-in details applicable
  • No partly paid-up shares, convertible securities, warrants, ESOPs, depository receipts, locked-in shares, pledged promoter shares, or differential voting rights

Regulatory Changes

The company transitions from the SME Emerge platform (a segment for small and medium enterprises) to the Main Board of NSE’s Capital Market Segment. This change subjects the company to Main Board listing obligations and compliance requirements under SEBI and NSE regulations.

Compliance Requirements

  • NSE members/brokers must update trading systems to reflect the new segment classification effective March 11, 2026
  • The company (Vital Chemtech Limited) must comply with Main Board listing and disclosure obligations from the effective date
  • Company Secretary: Ms. Atulaben Jagdishbhai Patel (compliance@vitalgroup.co.in)
  • Registrar: Skyline Financial Services Private Limited, New Delhi

Important Dates

  • March 09, 2026: Circular issued (Download Ref No: NSE/CML/73204)
  • March 11, 2026: Effective date of migration to Capital Market Segment (Main Board)

Impact Assessment

The migration of Vital Chemtech Limited to NSE’s Main Board increases the stock’s accessibility to a broader investor base, including institutional investors who may have restrictions on SME-platform securities. This typically improves liquidity and visibility for the company. For existing shareholders, the transition is seamless with the same ISIN and symbol retained. The shareholding pattern filed as of March 6, 2026 confirms no complex capital structures (no warrants, ESOPs, or pledged promoter shares), indicating a straightforward migration.

Impact Justification

Migration from SME to Main Board is a significant milestone for the company and its shareholders, broadening investor access and liquidity, but has limited systemic market impact.